Evidence map›Paper›PMID 39066304›Full record

ArticleViruses2024

Potential Role of APOBEC3 Family Proteins in SARS-CoV-2 Replication.

Mst Monira Begum, Ayub Bokani, Samiul Alam Rajib, Mohadeseh Soleimanpour, Yosuke Maeda, Kazuhisa Yoshimura, Yorifumi Satou, Diako Ebrahimi, Terumasa Ikeda

Abstract read
In one paragraph

Article in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. HAMMER: Hairpin-based APOBEC3A-mediated mRNA editing reporter.bioRxiv : the preprint server for biology · 2026
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mst Monira BegumDivision of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-0811, Japan.
Ayub BokaniSchool of Engineering and Technology, CQ University, Sydney, NSW 2000, Australia.ORCID 0000-0001-5160-7724
Samiul Alam RajibDivision of Genomics and Transcriptomics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-0811, Japan.ORCID 0000-0003-0743-1172
Mohadeseh SoleimanpourTexas Biomedical Research Institute, San Antonio, TX 78227, USA.
Yosuke MaedaDepartment of Microbiology, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
Kazuhisa YoshimuraTokyo Metropolitan Institute of Public Health, Tokyo 169-0073, Japan.
Yorifumi SatouDivision of Genomics and Transcriptomics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-0811, Japan.ORCID 0000-0002-1495-7810
Diako EbrahimiTexas Biomedical Research Institute, San Antonio, TX 78227, USA.ORCID 0000-0002-8577-0420
Terumasa IkedaDivision of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-0811, Japan.ORCID 0000-0003-2869-9450

Funding

Viral and host determinants of donor-specific anti-HIV/SIV immunity mediated by APOBEC3-enzymeR01AI179465 · NIAID · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Diako Ebrahimi · 2024 to 2026
$2.5M
Donor-specific anti-HIV/SIV immunity mediated by APOBEC3 enzymesR56AI174877 · NIAID · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI EBRAHIMI, DIAKO · 2023 to 2023
$833k
Japan Agency for Medical Research and Development JP21fk0108494Japan Agency for Medical Research and Development JP22fk0108511Japan Agency for Medical Research and Development JP22fk0108534Japan Agency for Medical Research and Development JP22fk0410055Japan Agency for Medical Research and Development JP23fk0410052Japan Agency for Medical Research and Development JP23wm0325068JSPS KAKENHI Grant-in-Aid for Scientific Research C 22K07103NIAID NIH HHS R01 AI179465NIAID NIH HHS R56 AI174877
6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has acquired multiple mutations since its emergence. Analyses of the SARS-CoV-2 genomes from infected patients exhibit a bias toward C-to-U mutations, which are suggested to be caused by the apolipoprotein B mRNA editing enzyme polypeptide-like 3 (APOBEC3, A3) cytosine deaminase proteins. However, the role of A3 enzymes in SARS-CoV-2 replication remains unclear. To address this question, we investigated the effect of A3 family proteins on SARS-CoV-2 replication in the myeloid leukemia cell line THP-1 lacking

Indexed as

APOBEC DeaminasesCOVID-19Cytidine DeaminaseSARS-CoV-2Virus ReplicationAngiotensin-Converting Enzyme 2Genome, ViralHumansMutationTHP-1 CellsACE2 protein, humanAngiotensin-Converting Enzyme 2APOBEC3 proteins, humanAPOBEC DeaminasesCytidine DeaminaseAPOBEC3 family proteinsdeaminase-independent mechanismSARS-CoV-2THP-1

Identifiers

PMID39066304
PMCPMC11281575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.